Israel Past Earnings Performance
Past criteria checks 2/6
Israel has been growing earnings at an average annual rate of 28.4%, while the Chemicals industry saw earnings growing at 9.5% annually. Revenues have been growing at an average rate of 10.4% per year. Israel's return on equity is 7.4%, and it has net margins of 0.4%.
Key information
28.4%
Earnings growth rate
19.9%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | 10.4% |
| Return on equity | 7.4% |
| Net Margin | 0.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Israel makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 6,930 | 30 | 1,397 | 67 |
| 30 Jun 24 | 7,039 | 54 | 1,384 | 65 |
| 31 Mar 24 | 7,155 | 218 | 1,373 | 70 |
| 31 Dec 23 | 7,536 | 273 | 1,369 | 71 |
| 30 Sep 23 | 7,937 | 712 | 1,319 | 69 |
| 30 Jun 23 | 8,594 | 837 | 1,362 | 70 |
| 31 Mar 23 | 9,606 | 739 | 1,429 | 68 |
| 31 Dec 22 | 10,015 | 903 | 1,445 | 68 |
| 30 Sep 22 | 9,962 | 880 | 1,531 | 72 |
| 30 Jun 22 | 9,233 | 657 | 1,518 | 70 |
| 31 Mar 22 | 7,970 | 495 | 1,435 | 67 |
| 31 Dec 21 | 6,955 | 269 | 1,377 | 64 |
| 30 Sep 21 | 6,234 | 146 | 1,269 | 62 |
| 30 Jun 21 | 5,648 | 91 | 1,157 | 59 |
| 31 Mar 21 | 5,234 | -76 | 1,082 | 55 |
| 31 Dec 20 | 5,043 | -76 | 1,043 | 54 |
| 30 Sep 20 | 4,832 | -165 | 1,024 | 49 |
| 30 Jun 20 | 4,953 | -107 | 1,039 | 49 |
| 31 Mar 20 | 5,175 | 52 | 1,061 | 51 |
| 31 Dec 19 | 5,271 | 159 | 1,067 | 50 |
| 30 Sep 19 | 5,575 | 212 | 1,052 | 51 |
| 30 Jun 19 | 5,621 | 190 | 1,045 | 51 |
| 31 Mar 19 | 5,567 | 181 | 1,042 | 54 |
| 31 Dec 18 | 5,556 | 548 | 1,054 | 55 |
| 30 Sep 18 | 5,507 | 583 | 1,086 | 57 |
| 30 Jun 18 | 5,576 | 605 | 1,086 | 56 |
| 31 Mar 18 | 5,527 | 561 | 1,075 | 54 |
| 31 Dec 17 | 5,418 | 136 | 1,051 | 55 |
| 30 Sep 17 | 5,395 | 56 | 1,042 | 59 |
| 30 Jun 17 | 5,338 | -195 | 1,065 | 65 |
| 31 Mar 17 | 5,393 | -119 | 1,079 | 71 |
| 31 Dec 16 | 5,363 | -117 | 1,068 | 73 |
| 30 Sep 16 | 5,452 | -71 | 1,093 | 71 |
| 30 Jun 16 | 5,448 | 214 | 1,066 | 74 |
| 31 Mar 16 | 5,267 | 176 | 1,020 | 72 |
| 31 Dec 15 | 5,405 | 438 | 1,036 | 74 |
| 30 Sep 15 | 5,381 | 335 | 1,004 | 77 |
| 30 Jun 15 | 5,562 | 296 | 1,050 | 79 |
| 31 Mar 15 | 5,901 | 314 | 1,128 | 83 |
| 31 Dec 14 | 6,111 | 7 | 1,173 | 87 |
| 30 Sep 14 | 5,333 | 10 | 1,188 | 80 |
| 30 Jun 14 | 5,530 | -68 | 1,170 | 79 |
| 31 Mar 14 | 5,091 | -8 | 1,154 | 83 |
| 31 Dec 13 | 6,272 | -13 | 1,199 | 83 |
Quality Earnings: IRLC.F has high quality earnings.
Growing Profit Margin: IRLC.F's current net profit margins (0.4%) are lower than last year (9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IRLC.F's earnings have grown significantly by 28.4% per year over the past 5 years.
Accelerating Growth: IRLC.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: IRLC.F had negative earnings growth (-95.8%) over the past year, making it difficult to compare to the Chemicals industry average (4.8%).
Return on Equity
High ROE: IRLC.F's Return on Equity (7.4%) is considered low.